[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341152-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341152-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identification-of-people-with-lynch-syndrome-from-those-presenting-with-colorectal-cancer-in-england-baseline-analysis-of-the-diagnostic-pathway","Identiﬁcation of people with Lynch syndrome from those presenting with colorectal cancer in England - baseline analysis of the diagnostic pathway","","Belief that over 95% of people with Lynch syndrome remain undiagnosed contrasts with National Health Service guidance that all colorectal cancers should be tested for DNA mismatch repair deficiency. Using a comprehensive national dataset, retrospective baseline follow-up of CRC cases in England in 2019 assessed molecular testing for dMMR, MLH1 promoter methylation and BRAF, and germline MMR gene testing. Only 44% received dMMR screening, 51% proceeded to further diagnostics, and just 1.3% had germline testing, with up to 37% outside NICE guidance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-of-people-with-lynch-syndrome-from-those-presenting-with-colorectal-cancer-in-england-baseline-analysis-of-the-diagnostic-pathway/341152/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-of-people-with-lynch-syndrome-from-those-presenting-with-colorectal-cancer-in-england-baseline-analysis-of-the-diagnostic-pathway/341152.png","ImageObject",300,407,{"name":42,"@type":43},"Aurora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is Lynch syndrome underdiagnosed in England?","Question",{"text":63,"@type":64},"The study notes that more than 95% of people with Lynch syndrome are believed to remain undiagnosed. Attrition occurs at multiple stages of the molecular testing pathway, limiting identification.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What molecular tests are included in the diagnostic pathway analysis?",{"text":68,"@type":64},"Baseline follow-up incorporated somatic tumour testing for dMMR (via immunohistochemistry or microsatellite instability), additional tumour testing for MLH1 promoter methylation and BRAF status, and constitutional germline testing of MMR genes.",{"name":70,"@type":61,"acceptedAnswer":71},"How often were CRCs tested for dMMR and what happened afterward?",{"text":72,"@type":64},"Only 44% of colorectal cancers were screened for dMMR. Among those identified as dMMR, only 51% underwent subsequent diagnostic testing.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341152,1790214203,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":124,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www.nature.com/ejhg](www.nature.com/ejhg)  \nARTICLE OPEN   \nIdentiﬁcation of people with Lynch syndrome from those presenting with colorectal cancer in England: baseline analysis of the diagnostic pathway  \nFiona E. McRonald 1 ✉ , Joanna Pethick1, Francesco Santaniello 1,2, Brian Shand1,2, Adele Tyson 1,3, Oliver Tulloch 1,2, Shilpi Goel1,2, Margreet Lüchtenborg 1,4, Gillian M. Borthwick5, Clare Turnbull6, Adam C. Shaw3, Kevin J. Monahan7, Ian M. Frayling 7,8,  \nSteven Hardy1 and John Burn 5 ✉  \n© The Author(s) 2024  \n\n| | It is believed that >95% of people with Lynch syndrome (LS) remain undiagnosed. Within the National Health Service (NHS) in England, formal guidelines issued in 2017 state that all colorectal cancers (CRC) should be tested for DNA Mismatch Repair deﬁciency (dMMR) . We used a comprehensive population-level national dataset to analyse implementation of the agreed diagnostic pathway at a baseline point 2 years post-publication of ofﬁcial guidelines. Using real-world data collected and curated by the National Cancer Registration and Analysis Service (NCRAS), we retrospectively followed up all people diagnosed with CRC in England in 2019 . Nationwide laboratory diagnostic data incorporated somatic (tumour) testing for dMMR (via immunohistochemistry or microsatellite instability), somatic testing for MLH1 promoter methylation and BRAF status, and constitutional (germline) testing of MMR genes. Only 44% of CRCs were screened for dMMR; these ﬁgures varied over four-fold with respect to geography. Of those CRCs identiﬁed as dMMR, only 51% underwent subsequent diagnostic testing. Overall, only 1.3% of patients with colorectal cancer had a germline MMR genetic test performed; up to 37% of these tests occurred outside of NICE guidelines. The low rates of molecular diagnostic testing in CRC support the premise that Lynch syndrome is underdiagnosed, with signiﬁcant attrition at all stages of the testing pathway. Applying our methodology to subsequent years’ data will allow ongoing monitoring and analysis of the impact of recent investment. If the diagnostic guidelines were fully implemented, we estimate that | |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | up to 700 additional people with LS could be identiﬁed each year. |  |\n|  |  |  |\n|  |  |  |\n|  | European Journal of Human Genetics (2024) 32:529–538; [https://doi.org/10.1038/s41431-024-01550-w](https://doi.org/10.1038/s41431-024-01550-w) |  |\n|  |  |  |\n\nINTRODUCTION  \nAt least 3% of cancers are attributable to constitutional (germline) pathogenic variants in a cancer susceptibility gene (CSG) [1] . Families harbouring these constitutional pathogenic variants were classically ascertained by clinical geneticists, based on familial clustering of related tumour types in several relatives, multiple primary tumours in some individuals, and tumour development ata younger age than typical for that cancer type. However, more widespread availability of molecular diagnostics has revealed other individuals who carry a similar genetic predisposition, but with a more subtle familial phenotype, or absence of a family history of similar cancers [2, 3] . Ascertainment has therefore been biased towards the classical familial pattern rather than the individual’s own phenotype.  \nThe Mismatch Repair (MMR) family of proteins is responsible for rectifying DNA replication errors that arise during the S-phase of the cell cycle. Germline pathogenic variants affecting any of the four MMR genes MLH1, MSH2, MSH6 or PMS2 underlie Lynch syndrome (LS), conferring a strong predisposition towards various  \ncancers—predominantly colorectal and endometrial carcinoma, but also others including urothelial, ovarian, and upper gastrointestinal cancers, and sebaceous dermatological tumours [4] . Estimates of the true population prevalence of LS [5–7] indicate substantial underdiagnos","cbCaigMkqMte6OyJ","https://ap.wps.com/l/cbCaigMkqMte6OyJ","pdf",2122984,"English","# Introduction\n## Diagnostic pathway baseline analysis\n## Testing for dMMR and follow-up molecular diagnostics\n## Germline MMR gene testing and guideline adherence","[{\"question\":\"Why is Lynch syndrome underdiagnosed in England?\",\"answer\":\"The study notes that more than 95% of people with Lynch syndrome are believed to remain undiagnosed. Attrition occurs at multiple stages of the molecular testing pathway, limiting identification.\"},{\"question\":\"What molecular tests are included in the diagnostic pathway analysis?\",\"answer\":\"Baseline follow-up incorporated somatic tumour testing for dMMR (via immunohistochemistry or microsatellite instability), additional tumour testing for MLH1 promoter methylation and BRAF status, and constitutional germline testing of MMR genes.\"},{\"question\":\"How often were CRCs tested for dMMR and what happened afterward?\",\"answer\":\"Only 44% of colorectal cancers were screened for dMMR. Among those identified as dMMR, only 51% underwent subsequent diagnostic testing.\"}]","Identiﬁcation of people with Lynch syndrome from those presenting with colorectal cancer in England - baseline analysis of the diagnostic pathway | PDF",1790040579,25,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6886799f0010690242e407952433c5d.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9332304dd943117be0ea2b11fb4e126b.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ea2bd7c5d903256b02e3904608a2e1f.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a30d0f19172420f59887f001fa22d6e.webp",980,1301]